Femme et Homme | 18 ans et plus
- | Pays :
- France
- | Organes :
- Tumeurs solides
- | Spécialités :
- Thérapies Ciblées
Extrait
A multicenter, open label, phase I trial of the MEK inhibitor AS703026 given orally to subjects with solid tumours
A multicenter, open label, phase I trial of the MEK inhibitor AS703026 given orally to subjects with solid tumours